Medical Marijuana, Inc., a pioneering leader in the cannabis industry, is headquartered in the United States and operates across various regions, including North America and Europe. Founded in 2009, the company has made significant strides in the development and distribution of hemp-derived CBD products, positioning itself as a trusted name in the market. The company offers a diverse range of products, including CBD oils, edibles, and topical solutions, all distinguished by their commitment to quality and innovation. Medical Marijuana, Inc. is notable for being the first publicly traded cannabis company in the U.S., achieving numerous milestones in regulatory compliance and product development. With a strong market presence and a dedication to advancing the benefits of medical cannabis, Medical Marijuana, Inc. continues to lead the way in the evolving landscape of hemp-based wellness solutions.
How does Medical Marijuana, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medical Marijuana, Inc.'s score of 19 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Marijuana, Inc., headquartered in the US, currently does not have any reported carbon emissions data for the most recent year, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, the organisation's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent company or corporate family. Without specific emissions data or reduction initiatives, it is challenging to assess their environmental impact or commitment to sustainability within the industry context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medical Marijuana, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
